3,245 results match your criteria: "Chorioretinopathy Central Serous"
Int J Retina Vitreous
December 2024
Federal University of São Paulo, São Paulo, Brazil.
Background: Central serous chorioretinopathy (CSC) is marked by serous retinal detachments caused by fluid leakage from the retinal pigment epithelium, often associated with stress, psychiatric disorders and the use of corticosteroids. This study aims to investigate the clinical and systemic characteristics associated with BALAD in patients with CSC, comparing those with and without BALAD to clarify its function as a biomarker of CSC severity and improve diagnostic and treatment approaches.
Purpose: Compare the clinical characteristics, risk factors, and optical coherence tomography (OCT) findings in patients with Central Serous Chorioretinopathy (CSC) with and without Bacillary Layer Detachment (BALAD), and to identify the distinguishing features and associated conditions of CSC with BALAD.
Transl Vis Sci Technol
December 2024
Ophthalmology Clinic, Department of Medicine and Science of Ageing, "G. d'Annunzio" University Chieti-Pescara, Chieti, Italy.
Purpose: To analyze choroidal and choriocapillaris changes in eyes affected by active unilateral central serous chorioretinopathy (CSC).
Methods: A total of 17 eyes suffering from naïve CSC were enrolled. In addition, 17 healthy fellow eyes were analyzed, and 10 eyes were enrolled as controls.
Cureus
November 2024
Gastroenterology, Lahore General Hospital, Lahore, PAK.
Background: Central serous chorioretinopathy (CSC) is a significant cause of vision loss in men aged 20 to 60, characterized by serous detachment of the neurosensory retina from the retinal pigment epithelium (RPE). This study aims to assess the frequency of CSC among patients at a tertiary care center in Pakistan, offering insights into its epidemiology and management within this setting.
Methodology: A retrospective observational study was conducted at the ophthalmology department of a tertiary care center from January 2019 to December 2023.
Ophthalmologie
December 2024
Klinik für Augenheilkunde, Universitätsklinikum des Saarlandes, Homburg/Saar, Deutschland.
Retin Cases Brief Rep
November 2024
Northern California Kaiser Permanente, Roseville, CA, USA.
Purpose: We describe a case of bilateral chronic central serous chorioretinopathy (CSCR) secondary to adrenal cortical carcinoma.
Methods: Case report of a 70-year-old Hispanic man presenting with bilateral multifocal CSCR.
Results: Clinical findings of bilateral chronic CSCR along with 160 µm of subretinal fluid (SRF) and choroidal thickness greater than 400 µm without enhanced depth optical coherence tomography was noted in a patient presenting with distortion in vision in both eyes and weight gain of 15 pounds, weakness, and fatigue starting 8 months prior.
Retina
November 2024
Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
J Surg Case Rep
November 2024
Department of Opthamology, Princess Alexandra Hospital, Queensland Health, 99 Ipswich Rd, Woolloongabba 4012, Australia.
Am J Ophthalmol
November 2024
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address:
Purpose: To investigate the comparative efficacy and safety of half-dose photodynamic therapy (PDT) and half-fluence PDT in the management of chronic central serous chorioretinopathy (cCSCR).
Design: Systematic review and meta-analysis METHODS: A comprehensive literature search was conducted on Ovid MEDLINE, Embase, and the Cochrane Library, covering publications from January 2000 to March 2024. The review focused on studies reporting the efficacy and safety of half-dose PDT compared to half-fluence PDT in treating cCSCR.
Medicina (Kaunas)
November 2024
Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Sci Rep
November 2024
Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan.
Clin Pract
November 2024
Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
: Central serous chorioretinopathy (CSCR) is a retinal condition characterized by the accumulation of subretinal fluid, often linked to elevated levels of endogenous corticosteroids and stress-related hormones, which can lead to visual disturbances. This connection may explain the association of CSCR with high stress levels and the use of corticosteroid medications. Although many cases resolve spontaneously, persistent or severe instances may require intervention.
View Article and Find Full Text PDFGraefes Arch Clin Exp Ophthalmol
November 2024
Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Purpose: To comprehensively evaluate baseline characteristics of patients with central serous chorioretinopathy (CSC) and develop predictive risk scores to identify visual prognosis.
Methods: This single-institute, retrospective cohort study included 144 eyes of 144 patients with CSC who underwent photodynamic therapy and achieved serous retinal detachment resolution. We developed and assessed the performance of several risk scores for best-corrected visual acuity (BCVA) outcomes six months post-treatment: i) BCVA improvement (≤-1.
Vestn Oftalmol
November 2024
S.M. Kirov Military Medical Academy, Saint Petersburg, Russia.
Brolucizumab, an angiogenesis inhibitor, is a single-chain fragment of a humanized antibody used to treat neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Although registration studies are the primary source of information on the new drug, post-marketing studies allow for further exploration and expansion of previous knowledge about its effectiveness, safety, and dosing regimens. This study summarizes the experience with brolucizumab from real-world clinical practice studies.
View Article and Find Full Text PDFFront Med (Lausanne)
November 2024
Shenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen, China.
Int J Ophthalmol
November 2024
Nanjing Medical University Affiliated Eye Hospital, Nanjing 290091, Jiangsu Province, China.
Graefes Arch Clin Exp Ophthalmol
November 2024
Department of Ophthalmology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China.
Biomed Opt Express
November 2024
School of Electronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu, Sichuan 610054, China.
J Curr Ophthalmol
October 2024
Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Photodiagnosis Photodyn Ther
December 2024
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Qazvin Street, Tehran, Iran. Electronic address:
Am J Ophthalmol
November 2024
Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus (N.I., H.K.), Okinawa, Japan. Electronic address:
Ophthalmic Surg Lasers Imaging Retina
November 2024
Bullous serous central chorioretinopathy (bCSCR) is an atypical form of CSCR characterized by large serous detachment. This variant presents significant diagnostic challenges, and optimal treatment strategies are not well defined. This report presents a case of a 31-year-old man with bCSRC treated with scleral thinning surgery in four quadrants with scleral windows created in the two inferior quadrants.
View Article and Find Full Text PDFBMC Ophthalmol
November 2024
Southwest Hospital/Southwest Eye Hospital, Army Medical University, Chongqing, China.
Purpose: To research the therapeutic effects of 577 nm micropulse laser photocoagulation (MLP) treatment in early-stage central serous chorioretinopathy (CSCR) patients.
Methods: Twenty-two CSCR patients with 24 CSCR eyes were examined prior to MLP treatment. The examinations included best-corrected visual acuity (BCVA), fluorescein fundus angiography (FFA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), optical coherence tomography angiography (OCTA) and microperimetry.
Ophthalmic Genet
November 2024
Department of Ophthalmology, University of Yamanashi, Chuo, Japan.
Am J Ophthalmol
November 2024
Department of Ophthalmology and Visual Science (T.Y.), Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ophthalmol Retina
November 2024
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Cleveland Clinic Cole Eye Institute, Cleveland, Ohio. Electronic address: